FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2218442983> ?p ?o ?g. }

• W2218442983 endingPage "98" @default.
• W2218442983 startingPage "92" @default.
• W2218442983 abstract "Therapeutic drug monitoring in tuberculosis remains controversial. We evaluated the relationship between antituberculosis drug levels in blood and clinical outcome. Serum concentrations of first-line antituberculosis drugs were measured in tuberculosis patients between March 2006 and April 2013. Venous blood was drawn 2 h after drug ingestion and was analyzed using high-performance liquid chromatography-tandem mass spectrometry. We retrospectively reviewed the data and determined the association of serum drug levels with clinical outcome. Among 413 patients, the prevalences of low serum concentrations of isoniazid (INH), rifampin (RMP), ethambutol (EMB), and pyrazinamide (PZA) were 59.9%, 27.8%, 12.8%, and 8.7%, respectively. The low INH group had a greater percentage of patients with a history of tuberculosis treatment (19.2% versus 11.0%; P = 0.026) and was more likely to present with drug-resistant strains (17.6% versus 8.8%; P = 0.049) than the normal INH group; however, low levels of INH, RMP, EMB, and PZA were not related to treatment outcome. Low INH level had a tendency to be associated with 2-month culture positivity, but it was not statistically significant (P = 0.072) in multivariate analysis. Seventeen (4.1%) patients experienced a recurrence. However, the recurrence rate was not statistically different between the low and normal INH groups. Low serum INH may play a role in recurrence and in acquired drug resistance. However, the serum level of INH was not directly related to either treatment response or recurrence rate. The role and usefulness of therapeutic drug monitoring should be evaluated in further prospective studies." @default.
• W2218442983 created "2016-06-24" @default.
• W2218442983 creator A5021661618 @default.
• W2218442983 creator A5023982303 @default.
• W2218442983 creator A5024697965 @default.
• W2218442983 creator A5030045699 @default.
• W2218442983 creator A5030817312 @default.
• W2218442983 creator A5036124455 @default.
• W2218442983 creator A5037673037 @default.
• W2218442983 creator A5049511963 @default.
• W2218442983 creator A5066672164 @default.
• W2218442983 date "2016-01-01" @default.
• W2218442983 modified "2023-10-18" @default.
• W2218442983 title "Serum Levels of Antituberculosis Drugs and Their Effect on Tuberculosis Treatment Outcome" @default.
• W2218442983 cites W1971385179 @default.
• W2218442983 cites W1982334998 @default.
• W2218442983 cites W1995044095 @default.
• W2218442983 cites W2019883403 @default.
• W2218442983 cites W2027951201 @default.
• W2218442983 cites W2042333540 @default.
• W2218442983 cites W2061472088 @default.
• W2218442983 cites W2065796979 @default.
• W2218442983 cites W2075098875 @default.
• W2218442983 cites W2078032948 @default.
• W2218442983 cites W2087929993 @default.
• W2218442983 cites W2095750649 @default.
• W2218442983 cites W2097133372 @default.
• W2218442983 cites W2098248535 @default.
• W2218442983 cites W2107834145 @default.
• W2218442983 cites W2133530219 @default.
• W2218442983 cites W2135355814 @default.
• W2218442983 cites W2147213334 @default.
• W2218442983 cites W2151487264 @default.
• W2218442983 cites W2163094860 @default.
• W2218442983 cites W2170012142 @default.
• W2218442983 cites W2170452898 @default.
• W2218442983 cites W60816396 @default.
• W2218442983 doi "https://doi.org/10.1128/aac.00693-15" @default.
• W2218442983 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4704228" @default.
• W2218442983 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26459901" @default.
• W2218442983 hasPublicationYear "2016" @default.
• W2218442983 type Work @default.
• W2218442983 sameAs 2218442983 @default.
• W2218442983 citedByCount "50" @default.
• W2218442983 countsByYear W22184429832016 @default.
• W2218442983 countsByYear W22184429832017 @default.
• W2218442983 countsByYear W22184429832018 @default.
• W2218442983 countsByYear W22184429832019 @default.
• W2218442983 countsByYear W22184429832020 @default.
• W2218442983 countsByYear W22184429832021 @default.
• W2218442983 countsByYear W22184429832022 @default.
• W2218442983 countsByYear W22184429832023 @default.
• W2218442983 crossrefType "journal-article" @default.
• W2218442983 hasAuthorship W2218442983A5021661618 @default.
• W2218442983 hasAuthorship W2218442983A5023982303 @default.
• W2218442983 hasAuthorship W2218442983A5024697965 @default.
• W2218442983 hasAuthorship W2218442983A5030045699 @default.
• W2218442983 hasAuthorship W2218442983A5030817312 @default.
• W2218442983 hasAuthorship W2218442983A5036124455 @default.
• W2218442983 hasAuthorship W2218442983A5037673037 @default.
• W2218442983 hasAuthorship W2218442983A5049511963 @default.
• W2218442983 hasAuthorship W2218442983A5066672164 @default.
• W2218442983 hasBestOaLocation W22184429831 @default.
• W2218442983 hasConcept C112705442 @default.
• W2218442983 hasConcept C114851261 @default.
• W2218442983 hasConcept C126322002 @default.
• W2218442983 hasConcept C141071460 @default.
• W2218442983 hasConcept C142724271 @default.
• W2218442983 hasConcept C2776228421 @default.
• W2218442983 hasConcept C2776967927 @default.
• W2218442983 hasConcept C2777975735 @default.
• W2218442983 hasConcept C2778607973 @default.
• W2218442983 hasConcept C2780035454 @default.
• W2218442983 hasConcept C2780272996 @default.
• W2218442983 hasConcept C2780459521 @default.
• W2218442983 hasConcept C2781069245 @default.
• W2218442983 hasConcept C500440147 @default.
• W2218442983 hasConcept C71924100 @default.
• W2218442983 hasConcept C86803240 @default.
• W2218442983 hasConcept C89423630 @default.
• W2218442983 hasConcept C90924648 @default.
• W2218442983 hasConcept C98274493 @default.
• W2218442983 hasConceptScore W2218442983C112705442 @default.
• W2218442983 hasConceptScore W2218442983C114851261 @default.
• W2218442983 hasConceptScore W2218442983C126322002 @default.
• W2218442983 hasConceptScore W2218442983C141071460 @default.
• W2218442983 hasConceptScore W2218442983C142724271 @default.
• W2218442983 hasConceptScore W2218442983C2776228421 @default.
• W2218442983 hasConceptScore W2218442983C2776967927 @default.
• W2218442983 hasConceptScore W2218442983C2777975735 @default.
• W2218442983 hasConceptScore W2218442983C2778607973 @default.
• W2218442983 hasConceptScore W2218442983C2780035454 @default.
• W2218442983 hasConceptScore W2218442983C2780272996 @default.
• W2218442983 hasConceptScore W2218442983C2780459521 @default.
• W2218442983 hasConceptScore W2218442983C2781069245 @default.
• W2218442983 hasConceptScore W2218442983C500440147 @default.
• W2218442983 hasConceptScore W2218442983C71924100 @default.
• W2218442983 hasConceptScore W2218442983C86803240 @default.

• next